AXGN
AxoGen, Inc.NASDAQHealthcare$34.44+2.56%ClosedMarket Cap: $1.79B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
11.89
P/S
7.52
EV/EBITDA
190.12
DCF Value
$-25.71
FCF Yield
-0.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
74.3%
Operating Margin
-3.5%
Net Margin
-7.0%
ROE
-13.4%
ROA
-7.1%
ROIC
-3.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $59.9M | 74.1% | $-9.8M | $-13.2M | $-0.28 | — |
| FY 2025 | $225.2M | 74.3% | $-7.8M | $-15.7M | $-0.34 | — |
| Q3 2025 | $60.1M | 76.6% | $1.9M | $708.0K | $0.01 | — |
| Q2 2025 | $56.7M | 74.2% | $1.7M | $579.0K | $0.01 | — |
| Q1 2025 | $48.6M | 71.9% | $-1.7M | $-3.8M | $-0.08 | — |
| Q4 2024 | $49.4M | 76.1% | $2.0M | $450.0K | $0.01 | — |
| FY 2024 | $187.3M | 75.8% | $-3.3M | $-10.0M | $-0.23 | — |
| Q3 2024 | $48.6M | 74.9% | $-316.0K | $-1.9M | $-0.04 | — |
| Q2 2024 | $47.9M | 73.8% | $-428.0K | $-1.9M | $-0.04 | — |
| Q1 2024 | $41.4M | 78.8% | $-4.6M | $-6.6M | $-0.15 | — |
| Q4 2023 | $42.9M | 78.7% | $-3.2M | $-3.9M | $-0.09 | — |
| FY 2023 | $159.0M | 76.6% | $-21.5M | $-21.7M | $-0.51 | — |